
Terns Pharmaceuticals Investor Relations Material
Latest events

Study Result
Terns Pharmaceuticals

Corporate Presentation
6 Jun, 2025

Q1 2025
8 May, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Terns Pharmaceuticals Inc
Access all reports
Terns Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company focusing on the development of a diverse portfolio of small-molecule therapeutic candidates. The company's research and development efforts are primarily focused on addressing serious diseases, including oncology, non-alcoholic steatohepatitis (NASH), and obesity.
Key slides for Terns Pharmaceuticals Inc


43rd Annual J.P. Morgan Healthcare Conference 2025
Terns Pharmaceuticals Inc


Corporate Presentation
Terns Pharmaceuticals Inc
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
TERN
Country
🇺🇸 United States